148 related articles for article (PubMed ID: 23519359)
1. 125I seed implant brachytherapy for the treatment of parotid gland cancers in children and adolescents.
Zheng L; Zhang J; Song T; Zhang J; Yu G; Zhang Y
Strahlenther Onkol; 2013 May; 189(5):401-6. PubMed ID: 23519359
[TBL] [Abstract][Full Text] [Related]
2. 125I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors.
Zhang J; Zhang JG; Song TL; Zhen L; Zhang Y; Zhang KH; Yang ZH; Yu GY
Int J Oral Maxillofac Surg; 2008 Jun; 37(6):515-20. PubMed ID: 18508237
[TBL] [Abstract][Full Text] [Related]
3. The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy: incidence of radioepidermitis and the dose-response relationship.
Mao MH; Zhang JG; Zheng L; Gao H; Zhang J; Liu SM; Huang MW; Shi Y
Strahlenther Onkol; 2015 Jan; 191(1):26-33. PubMed ID: 25200358
[TBL] [Abstract][Full Text] [Related]
4. Brachytherapy for recurrent malignant tumours of the parotid gland.
Zhang J; Zheng L; Liu SM; Huang MW; Shi Y; Wang W; Zhang JG
Br J Oral Maxillofac Surg; 2015 Jan; 53(1):58-62. PubMed ID: 25445387
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study of treating parotid gland malignant tumor with saving facial nerve (surgery associated with 125I seed implant brachytherapy)].
Zhanf JG; Zhang J; Song TL; Zheng L; Cai ZG; Yu GY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):132-5. PubMed ID: 18788543
[TBL] [Abstract][Full Text] [Related]
6. Postoperative [¹²⁵I] seed brachytherapy in the treatment of acinic cell carcinoma of the parotid gland: with associated risk factors.
Mao MH; Zhang JG; Zhang J; Zheng L; Liu SM; Huang MW; Shi Y
Strahlenther Onkol; 2014 Oct; 190(11):1008-14. PubMed ID: 24781865
[TBL] [Abstract][Full Text] [Related]
7. Iodine-125 brachytherapy alone for advanced primary parotid gland carcinoma.
Zhou C; Zhang J; Zhang JG; Liu SM; Zheng L; Huang MW; Shi Y; Lv XM
Int J Oral Maxillofac Surg; 2018 May; 47(5):561-567. PubMed ID: 28966067
[TBL] [Abstract][Full Text] [Related]
8. [125I seed implant brachytherapy of recurrent parotid gland malignant tumor].
Zhang J; Zhang JG; Cai ZG; Zhang Y; Huang MX; Yu GY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jan; 44(1):2-4. PubMed ID: 19489249
[TBL] [Abstract][Full Text] [Related]
9. Surgery combined with postoperative
Mao MH; Zheng L; Wang XM; Li H; Qin LZ; Zhang J; Han ZX; Zhang JG
Pediatr Blood Cancer; 2017 Jan; 64(1):57-63. PubMed ID: 27576792
[TBL] [Abstract][Full Text] [Related]
10. Preliminary results of (125)I interstitial brachytherapy for locally recurrent parotid gland cancer in previously irradiated patients.
Zheng L; Zhang J; Zhang J; Song T; Huang M; Yu G
Head Neck; 2012 Oct; 34(10):1445-9. PubMed ID: 22488812
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of surgery combined with postoperative
Li J; Zhang J; Lyu XM; Huang MW; Zheng L; Zhang JG
Pediatr Blood Cancer; 2020 Jul; 67(7):e28343. PubMed ID: 32391970
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combined surgery and
Wu ZY; Wu WJ; Zheng L; Huang MW; Shi Y; Lv XM; Liu SM; Zhang JG; Zhang J
Head Neck; 2019 Sep; 41(9):3219-3225. PubMed ID: 31116488
[TBL] [Abstract][Full Text] [Related]
13. Iodine-125 brachytherapy for the treatment of a large parotid epithelial-myoepithelial carcinoma in a child.
Zhang J; Zhen L; Zhang JG; Yu GY
Int J Oral Maxillofac Surg; 2014 Dec; 43(12):1431-5. PubMed ID: 25240907
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional verification of ¹²⁵I seed stability after permanent implantation in the parotid gland and periparotid region.
Fan Y; Huang MW; Zheng L; Zhao YJ; Zhang JG
Radiat Oncol; 2015 Nov; 10():242. PubMed ID: 26597296
[TBL] [Abstract][Full Text] [Related]
15. Three-Dimensional Printed Plate-Guided
Liu J; Wu T; Man Q; Fidèle NB; Zheng Y; Liu B
J Oral Maxillofac Surg; 2018 Oct; 76(10):2113-2121. PubMed ID: 29856941
[TBL] [Abstract][Full Text] [Related]
16. (125)I interstitial brachytherapy for the treatment of myoepithelial carcinoma of the oral and maxillofacial region.
Zheng L; Lv X; Shi Y; Zhang Y; Yu G; Zhang J
Brachytherapy; 2016; 15(2):240-5. PubMed ID: 26778756
[TBL] [Abstract][Full Text] [Related]
17. [Radioactivity seeds interstitial brachytherapy treating malignant salivary gland tumors].
Zhang J; Zheng L; Huang MW; Liu SM; Jia LF; Shi Y; Yu GY; Zhang JG
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):272-5. PubMed ID: 21503125
[TBL] [Abstract][Full Text] [Related]
18. Radioactive seed migration following parotid gland interstitial brachytherapy.
Fan Y; Huang MW; Zhao YJ; Gao H; Zhang JG
Brachytherapy; 2017; 16(6):1219-1224. PubMed ID: 28927732
[TBL] [Abstract][Full Text] [Related]
19. The role of
Huang MW; Wu WJ; Lv XM; Yu GY; Zhang JG
Brachytherapy; 2018; 17(1):244-249. PubMed ID: 29102739
[TBL] [Abstract][Full Text] [Related]
20. Mandibular growth in survivors of pediatric parotid gland carcinoma treated with interstitial brachytherapy.
Wu WJ; Huang MW; Zhang GH; Zhao D; Zheng L; Yu GY; Zhang JG
Pediatr Blood Cancer; 2018 Sep; 65(9):e27223. PubMed ID: 29797637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]